Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
Crossref DOI link: https://doi.org/10.1186/1129-2377-15-54
Published Online: 2014-09-01
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khalil, Modar
Zafar, Hassan W
Quarshie, Victoria
Ahmed, Fayyaz
License valid from 2014-09-01
Article History
Received: 5 June 2014
Accepted: 6 August 2014
First Online: 1 September 2014